Biomarin Pharmaceutical Inc (BMRN)
63.16
+0.60
(+0.96%)
USD |
NASDAQ |
Nov 21, 14:22
Biomarin Pharmaceutical Price: 63.16 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 61.97 | 62.70 | 61.61 | 62.56 | 1.162M |
| Nov 19, 2024 | 61.57 | 62.03 | 61.15 | 61.97 | 1.891M |
| Nov 18, 2024 | 63.15 | 63.52 | 61.40 | 61.93 | 2.061M |
| Nov 15, 2024 | 66.05 | 66.05 | 63.22 | 63.42 | 1.687M |
| Nov 14, 2024 | 66.37 | 67.00 | 65.53 | 65.60 | 1.390M |
| Nov 13, 2024 | 66.18 | 67.00 | 66.00 | 66.66 | 1.455M |
| Nov 12, 2024 | 65.96 | 66.69 | 65.80 | 66.13 | 1.152M |
| Nov 11, 2024 | 67.21 | 67.95 | 66.32 | 66.37 | 904817.0 |
| Nov 08, 2024 | 66.76 | 67.44 | 66.67 | 67.07 | 1.053M |
| Nov 07, 2024 | 66.32 | 67.30 | 65.76 | 66.94 | 1.351M |
| Nov 06, 2024 | 67.31 | 67.64 | 65.79 | 66.15 | 1.970M |
| Nov 05, 2024 | 66.23 | 66.23 | 65.45 | 66.04 | 1.614M |
| Nov 04, 2024 | 66.24 | 66.59 | 65.56 | 66.01 | 2.039M |
| Nov 01, 2024 | 65.70 | 66.81 | 65.60 | 66.60 | 1.644M |
| Oct 31, 2024 | 66.68 | 66.92 | 65.35 | 65.89 | 1.843M |
| Oct 30, 2024 | 69.67 | 69.67 | 65.78 | 66.68 | 2.784M |
| Oct 29, 2024 | 69.78 | 70.56 | 69.20 | 69.91 | 1.848M |
| Oct 28, 2024 | 69.92 | 70.71 | 69.60 | 70.13 | 1.544M |
| Oct 25, 2024 | 70.68 | 70.98 | 69.66 | 69.73 | 1.059M |
| Oct 24, 2024 | 70.05 | 70.98 | 69.58 | 70.39 | 1.120M |
| Oct 23, 2024 | 70.23 | 70.37 | 69.40 | 69.98 | 1.545M |
| Oct 22, 2024 | 69.72 | 70.74 | 69.50 | 70.53 | 1.220M |
| Oct 21, 2024 | 69.99 | 70.81 | 69.56 | 70.28 | 1.555M |
| Oct 18, 2024 | 69.70 | 70.13 | 69.29 | 70.11 | 1.510M |
| Oct 17, 2024 | 70.28 | 70.28 | 69.34 | 69.47 | 933323.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
61.93
Minimum
Nov 18 2024
131.03
Maximum
Jul 20 2020
86.96
Average
85.47
Median
Jul 02 2021
Price Benchmarks
| Merck & Co Inc | 99.29 |
| Bristol-Myers Squibb Co | 58.37 |
| Pfizer Inc | 24.99 |
| Biogen Inc | 158.07 |
| Moderna Inc | 37.67 |
Price Related Metrics
| PE Ratio | 37.82 |
| PS Ratio | 4.505 |
| PEG Ratio | 0.3226 |
| Price to Book Value | 2.224 |
| Price to Free Cash Flow | 41.22 |
| Earnings Yield | 2.64% |
| Market Cap | 12.04B |
| PEGY Ratio | 0.3226 |
| Operating PE Ratio | 39.70 |
| Normalized PE Ratio | 38.80 |